Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Since leronlimab is a humanized monoclonal IgG4 an

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 153886
(Total Views: 559)
Posted On: 05/26/2022 2:18:40 PM
Avatar
Posted By: chuckles759
Re: havasu78 #123802
Since leronlimab is a humanized monoclonal IgG4 antibody it falls into the immunoglobulin G (IgG) family. All classes of IgG have a similar molecular mass but have differing binding and triggering characteristics.

Good discussion of IgG subclasses and Allotypes can be found here.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202688/

They are working on it and have been very successful in determining the most efficient administration techniques as seen in this study.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851908/
Quote:
In summary, our data demonstrate that a significant fraction of systemically administered IVIg reaches the cerebral microvessels and enters the brain through a saturable transport across the BBB. To our knowledge, this study is the first to provide quantitative measurement of IVIg brain entry and suggests that IVIg may interact with therapeutic targets within the CNS, in the absence of BBB leakage.


A deep dive on mAb pathways across the BBB can be read here:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023012/

Long story short....Yes, the precedent has been proven successfully, now to see if the scientific medical community can perform a study specifically on leronlimab. Need a partner like MD Anderson, Thomas Jefferson University, or other respected research institution to take that on.


(5)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us